ID: ALA3952750

Max Phase: Preclinical

Molecular Formula: C4H2K2O4

Molecular Weight: 192.25

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C([O-])/C=C\C(=O)[O-].[K+].[K+]

Standard InChI:  InChI=1S/C4H4O4.2K/c5-3(6)1-2-4(7)8;;/h1-2H,(H,5,6)(H,7,8);;/q;2*+1/p-2/b2-1-;;

Standard InChI Key:  SHPKCSFVQGSAJU-UAIGNFCESA-L

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 192.25

Molecular Weight (Monoisotopic): 191.9227

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1.  (2001)  Identification of modulators of GPR41 or GPR42 activity, 

Source

Source(1):

• Patent Bioactivity Data